Last Updated : February 9, 2022
Details
FilesProject Status:
Completed
Project Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1207-000
Question
- What is the clinical effectiveness of post-exposure antibiotic chemoprophylaxis for the prevention of invasive group A streptococcal (iGAS) disease in close contacts of people with iGAS disease?
- What is the cost-effectiveness of post-exposure antibiotic chemoprophylaxis for the prevention of iGAS disease in close contacts of people with iGAS disease?
- What are the evidence-based guidelines regarding the use of post-exposure antibiotic chemoprophylaxis for the prevention of iGAS disease in close contacts of people with iGAS disease?
Key Message
No evidence was identified regarding the clinical effectiveness of post-exposure antibiotic chemoprophylaxis for the prevention of invasive group A streptococcal disease in close contacts of people with invasive group A streptococcal disease.
No evidence was identified regarding the cost-effectiveness of post-exposure antibiotic chemoprophylaxis for the prevention of invasive group A streptococcal disease in close contacts of people with invasive group A streptococcal disease.
Two evidence-based guidelines were identified regarding the use of post-exposure antibiotic chemoprophylaxis for the prevention of invasive group A streptococcal disease in close contacts of people with invasive group A streptococcal disease.
Files
Last Updated : February 9, 2022